Many congratulations to you and Saket...Fantastic work..Shilpee Dutt

Upcoming PhD intake 2024 Cancer Research Institute - ACTREC ACTREC-TMC Candidates who have qualified CSIR/DBT/ICMR/UGC can now apply for interviews through this link - shorturl.at/puxB7 Last date is 25th March! Biopatrika #research #cancer #science #CancerResearch

Another #PhD success with news that Tarang Gaur based in ACTREC-TMC #Mumbai with Syed K. Hasan has passed her #viva. Tarang spent part of her studies with Ahlam Ali in QUB Blood Cancer Research as part of her British Council funding. Good luck with your move to University of Washington in St Louis.

Extremely happy to complete my doctorate!!!! Immense love for my lab members and my mentor Syed K. Hasan . It was pleasure being your first student🌼 I am very thankful to entire ACTREC community for the wonderful PhD journey. Cancer Research Institute - ACTREC ACTREC-TMC Deepshikha Dutta Anup Jha

Congratulations, Akash Maity! What a proud moment seeing your 3rd-year PhD student present single-cell sequencing data on acute promyelocytic leukemia at a prestigious international meeting on APL. 🌟 #ResearchExcellence #ProudMentor Cancer Research Institute - ACTREC ACTREC-TMC Prantar Chakrabarti 3.0 Bhausaheb Bagal

Feeling deeply grateful for this proud moment! Thank you Syed K. Hasan Sir for the opportunity to witness and learn such groundbreaking research in APL. #research #APL

Presenting #poster at #EHA2024 and receiving prestigious #travel_grant_award is one of the best opportunities in my Ph.D tenure. A big thanks to my Ph.D guide Syed K. Hasan for all his support, help, and trust in me to achieve it.

This is an amazing piece of work in a very prestigious journal. Many congratulations to all of you

Many congratulations and very proud of you Tarang Gaur on winning soho young investigator fellowship at prestigious Society of Hematologic Oncology (SOHO) excellent work which is going soon in clinics. hope you will return to contribute to indian science again. Cancer Research Institute - ACTREC

Huge thanks to @AurigeneDiscov and Murali Ramachandra

(2) We developed CRISPR-Cas12 assay to detect PML-RARA isoforms on a lateral flow strip with ultimate goal of achieving equipment-free acute promyelocytic leukemia diagnosis suitable for OPD settings. Article: shorturl.at/Ymz93

Huge congratulations to my amazing student-friends for their outstanding work! CRISPR-Cas system is set to revolutionize cancer diagnostics. Proud of this brilliant team! ACTREC-TMC AML Hub Blood Advances @BloodJournal Cancer Research Institute - ACTREC Tata Memorial Hospital

Great. Proud of the entire team #CRISPR #APL #POC

I'm thrilled to announce that my paper in redox biology is finally out! This milestone marks my first solo corresponding author publication, a significant achievement i'm proud to share. Seeing the final product is surreal, and I'm grateful to share this moment with you. (1/6)

Led by Drs. Jayastu Senapati (Jayastu Senapati) and Naval Daver (Naval Daver, M.D.), this retrospective analysis in Haematologica included patients with newly diagnosed #MyelodysplasticSyndrome and #AML with TP53 mutations. 🩺 💡 Learn more: bit.ly/4gjHZYr

Full version article out now!! Congratulations Syed K. Hasan Lab and Akash Maity Biopatrika ACTREC-TMC Blood Advances ashpublications.org/bloodadvances/…

Sunday reading with your coffee! thehindu.com/sci-tech/rare-… ACTREC-TMC Cancer Research Institute - ACTREC Society of Hematologic Oncology (SOHO) European Hematology Association Blood Advances

2012 a friend said- “Science Fiction” 2015 we dared to dream Sharing 🇮🇳 1st novel #CARTCellRx Ph 1/1b trial We report 92% ORR 3 dose levels nature Blood Cancer Journal Rahul Purwar ImmunoACT CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC Nirali Shah Tata Memorial Hospital Swaminathan K Alka Dwivedi rdcu.be/ei7xh

Historical #Personalized_Gene_Editing to Treat an Inborn Error of Metabolism Disease causing DNA letter was corrected to a healthy version by #Adenine_Base_Editor (ABE) Great work Kiran Musunuru ABE was originally invented by Nicole M. Gaudelli David R. Liu nejm.org/doi/full/10.10…

Cases of Acute Myeloid Leukaemia (AML) - a rare, fast-growing cancer of the blood and bone marrow - are rising in the 30-40 age group. Individuals previously exposed to radiation or chemotherapy may be at higher risk. A simple blood test can help detect AML early.